Customer Award Winners Unveiled at Medidata NEXT Conference
Medidata, a Dassault Systèmes company, honored life sciences industry innovators and two inspirational leaders during its NEXT conference. A highly anticipated feature at the event, the Medidata NEXT Awards recognize excellence in collaboration, sustainability, digital innovation, and patient leadership.
"The clients who join us at our NEXT events are leaders in the industry, and we are proud to support them in powering smarter treatments and healthier people," said Michael Pray, Medidata COO. "We recognize and honor these companies for their continued innovation and leadership in accelerating clinical trials to benefit patients worldwide."
Medidata NEXT Awards include:
Collaboration of the Year Award - Accelerating clinical trial execution through collaboration:
Sustainability Award - Developing new treatments faster, safer, and with less environmental impact:
Digital Innovation Award - Leveraging data insights to improve decision making, driving innovation across clinical development:
Patient Leadership Award - Decreasing the burden o trial participants with a patient-first approach:
Pray added: "This year we introduced two special awards to honor true pioneers - those who left indelible marks on all who knew them. Glen de Vries and Linnea Olson inspired so many others to create positive change, and their commitment to improving the lives of patients will carry on forever."
Glen de Vries Epic Award - Inaugural award commemorating Medidata's co-founder, who inspired others to create transformational change
Linnea Olson Award - Named for a founding member of Medidata's Patient Insights Board
Medidata NEXT will be in Boston on April 25. Please see the full schedule of Medidata NEXT Global conferences on the Medidata website.
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 2,000+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com.
3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French "société européenne" (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230330005080/en/